Molecular pharmacology of CXCR4 inhibition

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In recent years, the chemokine receptor CXCR4 has been shown to be implemented in the mobilization of progenitor cells from the bone marrow. This fi nding has prompted a search for CXCR4 antagonists acting as stem cell mobilizing agents. In accordance, it is important to look into the molecular pharmacology of well-known CXCR4 antagonists in order to augment the potency and affi nity and to increase the specifi city of future CXCR4-targeting compounds. In this chapter, binding modes of CXCR4 antagonists that have been shown to mobilize stem cells are discussed. In addition, comparisons between results obtained from structure-function studies and fi ndings from newly released crystal structures are drawn.

Cite

CITATION STYLE

APA

Steen, A., & Rosenkilde, M. M. (2012). Molecular pharmacology of CXCR4 inhibition. In Novel Developments in Stem Cell Mobilization: Focus on CXCR4 (pp. 23–35). Springer US. https://doi.org/10.1007/978-1-4614-1960-0_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free